IP
STJ

Isthmus Partners’s St Jude Medical STJ Stock Holding History

Isthmus Partners’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-285
Closed -$23K – 318
2016
Q4 		$23K Hold
285
– – 0.01% 219
2016
Q3 		$22K Buy
285
+100
+54% +$8.07K 0.01% 213
2016
Q2 		$14K Hold
185
– – ﹤0.01% 221
2016
Q1 		$10K Sell
185
-100
-35% -$5.45K ﹤0.01% 228
2015
Q4 		$18K Hold
285
– – 0.01% 220
2015
Q3 		$18K Hold
285
– – 0.01% 224
2015
Q2 		$21K Hold
285
– – 0.01% 214
2015
Q1 		$19K Hold
285
– – 0.01% 217
2014
Q4 		$19K Buy
+285
New +$18.4K 0.01% 224

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Isthmus Partners's STJ Position: Q1 2017 in Review

Isthmus Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 285 shares — an estimated $23K sold.

Isthmus Partners first reported a position in STJ in Q4 2014 and held it in 9 quarters. The position peaked at $23K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Isthmus Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Isthmus Partners sold 285 St Jude Medical shares in Q1 2017, an estimated $23K.
  • Isthmus Partners first reported a position in St Jude Medical in Q4 2014 and held it in 9 quarters.
  • Isthmus Partners's St Jude Medical position peaked at $23K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Isthmus Partners's 13F filing for Q1 2017, filed 10 May 2017.